ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................*JBDM Ver 1.7.2 (20 November 2019) - 2999001/02668209CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120210811W173deBibliographieenBibliographyfrBibliographieEP12738907.0201201202013081320160629enenen201161435510 P20110124US2021081120213220131204201349202012302020532020072020210330BG20201230FI20201230HR20201230LV20201230RS20210811202132C07K 16/28 20060101AFI20200108BHEP A61K 39/395 20060101ALI20200108BHEP A61P 35/00 20060101ALI20200108BHEP C07K 16/46 20060101ALI20200108BHEP deFÜR ZELLEN MIT EGFR BEI HOHER DICHTE SELEKTIVE ANTIKÖRPERenANTIBODIES SELECTIVE FOR CELLS PRESENTING EGFR AT HIGH DENSITYfrANTICORPS SÉLECTIFS DES CELLULES PRÉSENTATRICES DES RÉCEPTEURS DE EGF À HAUTE DENSITÉWO-A1-96/40210WO-A2-2008/104183Ilia A. Tikhomirov ET AL: "Binding Binding Properties of Epidermal Growth Factor Receptor (EGFR) Targeted Monoclonal Antibodies: Factors Contributing to Differences in Observed Clinical Profiles (A36)", AACR Cancer Clinical Trials and Personalized Medicine, 1 August 2008 (2008-08-01), XP055197559, Retrieved from the Internet: URL:http://ymbiosciences.q4web.com/files/d oc_downloads/Nimotuzumab/poster_nimo_AACR_ Translational_Med_2008_v001_q194wg.pdf [retrieved on 2015-06-23]MELARKODE RAMAKRISHNAN ET AL: "Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin", MABS, 1 January 2009 (2009-01-01), pages 41-48, XP055173443,A. TALAVERA ET AL: "Nimotuzumab, an Antitumor Antibody that Targets the Epidermal Growth Factor Receptor, Blocks Ligand Binding while Permitting the Active Receptor Conformation", CANCER RESEARCH, vol. 69, no. 14, 15 July 2009 (2009-07-15) , pages 5851-5859, XP055197598, ISSN: 0008-5472, DOI: 10.1158/0008-5472.CAN-08-4518ARLHEE DIAZ MIQUELI ET AL: "Biological Activity In Vitro of Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies with Different Affinities", HYBRIDOMA, vol. 26, no. 6, 1 December 2007 (2007-12-01), pages 423-432, XP055197602, ISSN: 1554-0014, DOI: 10.1089/hyb.2007.0516CROMBET T ET AL: "Use of the Humanized Anti-Epidermal Growth Factor Receptor Monoclonal Antibody h-R3 in Combination with Advanced Head and Neck Cancer Patients", JOURNAL OF CLINICAL ONCOLOGY, AMERICAN SOCIETY OF CLINICAL ONCOLOGY, US, vol. 22, no. 9, 1 May 2004 (2004-05-01), pages 1646-1654, XP008131473, ISSN: 0732-183X, DOI: 10.1200/JCO.2004.03.089STEPHEN I. RUDNICK ET AL: "Affinity and Avidity in Antibody-Based Tumor Targeting", CANCER BIOTHERAPY & RADIOPHARMACEUTICALS, vol. 24, no. 2, 1 April 2009 (2009-04-01), pages 155-161, XP055069540, ISSN: 1084-9785, DOI: 10.1089/cbr.2009.0627MASAYUKI ODA ET AL: "Reevaluation of stoichiometry and affinity/avidity in interactions between anti-hapten antibodies and mono- or multi-valent antigens", MOLECULAR IMMUNOLOGY, vol. 37, no. 18, 1 December 2000 (2000-12-01), pages 1111-1122, XP055197715, ISSN: 0161-5890, DOI: 10.1016/S0161-5890(01)00028-1GRETA GARRIDO ET AL: "Bivalent binding by intermediate affinity of nimotuzumab: A contribution to explain antibody clinical profile", CANCER BIOLOGY & THERAPY, vol. 11, no. 4, 15 February 2011 (2011-02-15), pages 373-382, XP055197571, ISSN: 1538-4047, DOI: 10.4161/cbt.11.4.14097BOLAND, W ET AL.: 'The Emerging Role OfNimotuzumab In The Treatment Of Non-Small Cell Lung Cancer.' BIOLOGICS vol. 4, 09 November 2010, pages 289 - 298, XP055115351DONALDSON, J. M. ET AL.: 'Design And Development Of Masked Therapeutic Antibodies To Limit Off- Target Effects: Application To Anti-EGFR Antibodies.' CANCER BIOL THER vol. 8, November 2009, pages 2147 - 2152, XP00913577420150703TIKHOMIROV, Ilia Alexandre954 The QueenswayToronto Ontario M8Z 1P5CAJARAMILLO, Maria L.183 WestcroftBeaconsfield Québec H9W 2M2CAO'CONNOR-MCCOURT, Maureen D.186 SherbrookeBeaconsfield Québec H9W 1P2CASULEA, Traian61 Old ForestKirkland Québec H9J 3A2CAGILBERT, Renald5261 Avenue DohertyMontreal Québec H4V 2B4CAGAILLET, Bruno1772 Place MarseilleSainte Julienne Québec J0K 2T0CABAARDSNES, Jason6-1840 Rue MullinsMontreal Québec H3K 1N8CABANVILLE, Myriam595 LajeunesseLaval Québec H7X 3K4CAGROTHE, Suzanne688 BeattyMontreal Québec H4H 1X8CAGilead Sciences, Inc.101019425P2292EP00-KE3RE333 Lakeside DriveFoster City, CA 94404USNational Research Council of Canada101172603P2292EP00-KE3RE1200 Montreal Road Building M-58Ottawa, Ontario K1A 0R6CAGreaves Brewster LLP101746519Copa House Station RoadCheddar, Somerset BS27 3AHGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRCA201205003420120120enWO201210034620120802201231